Expert Review of Pharmacoeconomics and Outcomes Research
Journal Title
- Expert Review of Pharmacoeconomics and Outcomes Research
ISSN
- E 1744-8379 | P 1473-7167 | 1473-7167 | 1744-8379
Publisher
- Future Drugs Ltd.
Listed on(Coverage)
| JCR | 2012-2019 |
|---|---|
| SJR | 2002-2019 |
| CiteScore | 2011-2019 |
| SCIE | 2011-2021 |
| CC | 2016-2021 |
| SSCI | 2011-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points